F17.291 Nicotine dependence, other tobacco product, in remission

Billable ICD-10-CM code, FY2026.

Applicable to

• Tobacco use disorder, other tobacco product, mild, in early remission
• Tobacco use disorder, other tobacco product, mild, in sustained remission
• Tobacco use disorder, other tobacco product, moderate, in early remission
• Tobacco use disorder, other tobacco product, moderate, in sustained remission
• Tobacco use disorder, other tobacco product, severe, in early remission
• Tobacco use disorder, other tobacco product, severe, in sustained remission

Applies from F17 Nicotine dependence

Excludes1 (never code together)

• history of tobacco dependence (Z87.891)
• tobacco use NOS (Z72.0)

Excludes2 (not included here)

• tobacco use (smoking) during pregnancy, childbirth and the puerperium (O99.33-)
• toxic effect of nicotine (T65.2-)

MS-DRG index

Defines the logic of DRG(s) 951 in MDC 23.

Approximate ICD-9-CM (GEMs)

• 305.1 Tobacco use disorder (approximate)

Medicare Code Edits (MCE v43.1 (April 2026))

• Unacceptable principal diagnosis: These codes describe a circumstance which influences care but is not a current illness or injury, or capture only an underlying condition, and are unacceptable as principal diagnosis.

Code annotations containing back-references to F17.291

Back-references to F17.2

• Type 1 Excludes: Z72.0 Tobacco use ("nicotine dependence (F17.2-)")
• Type 1 Excludes: Z72.0 Tobacco use ("tobacco dependence (F17.2-)")
• Type 1 Excludes: Z87.891 Personal history of nicotine dependence ("current nicotine dependence (F17.2-)")

Back-references to F17

• Use Additional: C00 Malignant neoplasm of lip ("tobacco dependence (F17.-)")
• Use Additional: C01 Malignant neoplasm of base of tongue ("tobacco dependence (F17.-)")
• Use Additional: C02 Malignant neoplasm of other and unspecified parts of tongue ("tobacco dependence (F17.-)")
• Use Additional: C03 Malignant neoplasm of gum ("tobacco dependence (F17.-)")
• Use Additional: C04 Malignant neoplasm of floor of mouth ("tobacco dependence (F17.-)")
• Use Additional: C05 Malignant neoplasm of palate ("tobacco dependence (F17.-)")
• Use Additional: C06 Malignant neoplasm of other and unspecified parts of mouth ("tobacco dependence (F17.-)")
• Use Additional: C07 Malignant neoplasm of parotid gland ("tobacco dependence (F17.-)")
• Use Additional: C08 Malignant neoplasm of other and unspecified major salivary glands ("tobacco dependence (F17.-)")
• Use Additional: C09 Malignant neoplasm of tonsil ("tobacco dependence (F17.-)")
• Use Additional: C10 Malignant neoplasm of oropharynx ("tobacco dependence (F17.-)")
• Use Additional: C11 Malignant neoplasm of nasopharynx ("tobacco dependence (F17.-)")
• Use Additional: C12 Malignant neoplasm of pyriform sinus ("tobacco dependence (F17.-)")
• Use Additional: C13 Malignant neoplasm of hypopharynx ("tobacco dependence (F17.-)")
• Use Additional: C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx ("tobacco dependence (F17.-)")
• Use Additional: C32 Malignant neoplasm of larynx ("tobacco dependence (F17.-)")
• Use Additional: C33 Malignant neoplasm of trachea ("tobacco dependence (F17.-)")
• Use Additional: C34 Malignant neoplasm of bronchus and lung ("tobacco dependence (F17.-)")
• Use Additional: C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs ("tobacco dependence (F17.-)")
• Use Additional: D00.0 Carcinoma in situ of lip, oral cavity and pharynx ("tobacco dependence (F17.-)")
• Use Additional: D02 Carcinoma in situ of middle ear and respiratory system ("tobacco dependence (F17.-)")
• Type 2 Excludes: F02 Dementia in other diseases classified elsewhere ("dementia in alcohol and psychoactive substance disorders (F10-F19, with .17, .27, .97)")
• Type 2 Excludes: F06 Other mental disorders due to known physiological condition ("other mental disorders associated with alcohol and other psychoactive substances (F10-F19)")
• Type 2 Excludes: F06.0 Psychotic disorder with hallucinations due to known physiological condition ("hallucinations and perceptual disturbance induced by alcohol and other psychoactive substances (F10-F19 with .151, .251, .951)")
• Type 2 Excludes: F06.2 Psychotic disorder with delusions due to known physiological condition ("alcohol and drug-induced psychotic disorder (F10-F19 with .150, .250, .950)")
• Type 2 Excludes: F06.3 Mood disorder due to known physiological condition ("mood disorders due to alcohol and other psychoactive substances (F10-F19 with .14, .24, .94)")
• Type 2 Excludes: F06.4 Anxiety disorder due to known physiological condition ("anxiety disorders due to alcohol and other psychoactive substances (F10-F19 with .180, .280, .980)")
• Type 2 Excludes: F20 Schizophrenia ("psychoactive drug use (F11-F19 with .15. .25, .95)")
• Type 2 Excludes: F55 Abuse of non-psychoactive substances ("abuse of psychoactive substances (F10-F19)")
• Type 2 Excludes: F63 Impulse disorders ("habitual excessive use of alcohol or psychoactive substances (F10-F19)")
• Type 2 Excludes: F63.1 Pyromania ("alcohol or psychoactive substance intoxication (F10-F19)")
• Use Additional: G31.84 Mild cognitive impairment of uncertain or unknown etiology ("tobacco dependence (F17.-)")
• Use Additional: H65 Nonsuppurative otitis media ("tobacco dependence (F17.-)")
• Use Additional: H66 Suppurative and unspecified otitis media ("tobacco dependence (F17.-)")
• Use Additional: I20 Angina pectoris ("tobacco dependence (F17.-)")
• Use Additional: I21 Acute myocardial infarction ("tobacco dependence (F17.-)")
• Use Additional: I22 Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction ("tobacco dependence (F17.-)")
• Use Additional: I25 Chronic ischemic heart disease ("tobacco dependence (F17.-)")
• Use Additional: I70 Atherosclerosis ("tobacco dependence (F17.-)")
• Use Additional: J37 Chronic laryngitis and laryngotracheitis ("tobacco dependence (F17.-)")
• Use Additional: J40 Bronchitis, not specified as acute or chronic ("tobacco dependence (F17.-)")
• Use Additional: J41 Simple and mucopurulent chronic bronchitis ("tobacco dependence (F17.-)")
• Use Additional: J42 Unspecified chronic bronchitis ("tobacco dependence (F17.-)")
• Use Additional: J45 Asthma ("tobacco dependence (F17.-)")
• Use Additional: J47 Bronchiectasis ("tobacco dependence (F17.-)")
• Use Additional: J81 Pulmonary edema ("tobacco dependence (F17.-)")
• Use Additional: J98 Other respiratory disorders ("tobacco dependence (F17.-)")
• Use Additional: K05 Gingivitis and periodontal diseases ("tobacco dependence (F17.-)")
• Use Additional: K11 Diseases of salivary glands ("tobacco dependence (F17.-)")
• Use Additional: K12 Stomatitis and related lesions ("tobacco dependence (F17.-)")
• Use Additional: K13 Other diseases of lip and oral mucosa ("tobacco dependence (F17.-)")
• Use Additional: K14 Diseases of tongue ("tobacco dependence (F17.-)")
• Use Additional: K85.3 Drug induced acute pancreatitis ("code to identify drug abuse and dependence (F11.-F17.-)")
• Use Additional: O99.33 Tobacco use disorder complicating pregnancy, childbirth, and the puerperium ("code from category F17 to identify type of tobacco nicotine dependence")
• Type 1 Excludes: R41.3 Other amnesia ("amnestic syndrome due to psychoactive substance use (F10-F19 with 5th character .6)")
• Type 1 Excludes: R44 Other symptoms and signs involving general sensations and perceptions ("hallucinations in drug psychosis (F11-F19 with fifth to sixth characters 51)")
• Type 2 Excludes: R78 Findings of drugs and other substances, not normally found in blood ("mental or behavioral disorders due to psychoactive substance use (F10-F19)")
• Type 2 Excludes: T65.2 Toxic effect of tobacco and nicotine ("nicotine dependence (F17.-)")
• Use Additional: Z71.6 Tobacco abuse counseling ("code for nicotine dependence (F17.-)")
• Type 1 Excludes: Z77.22 Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) ("nicotine dependence (F17.-)")
• Type 2 Excludes: Z79 Long term (current) drug therapy ("drug abuse and dependence (F11-F19)")
• Use Additional: Z85 Personal history of malignant neoplasm ("tobacco dependence (F17.-)")

Diagnosis Index entries for F17.291

• Dependence (on) (syndrome) › drug NEC › nicotine › specified product NEC › with disorder › remission
• Disorder (of) › tobacco use › specified product NEC (mild) (moderate) (severe) › in remission (early) (sustained)

Nearby codes

• F17.223 Nicotine dependence, chewing tobacco, with withdrawal
• F17.228 Nicotine dependence, chewing tobacco, with other nicotine-induced disorders
• F17.229 Nicotine dependence, chewing tobacco, with unspecified nicotine-induced disorders
• F17.29 Nicotine dependence, other tobacco product
• F17.290 Nicotine dependence, other tobacco product, uncomplicated
• F17.291 Nicotine dependence, other tobacco product, in remission (this code)
• F17.293 Nicotine dependence, other tobacco product, with withdrawal
• F17.298 Nicotine dependence, other tobacco product, with other nicotine-induced disorders
• F17.299 Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders